Years after it was hyped, then vilified after the death of a teenager, then mostly forgotten by the general public, gene therapy has rebounded, and hospitals, companies, and investors in the Boston area have jumped on the bandwagon. David Williams, the Leland Fikes Professor of Pediatrics at Boston Children’s Hospital, is quoted.
